June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Test of the Robustness of an OCT-based Method for Identifying Glaucomatous Damage Across Different Instruments
Author Affiliations & Notes
  • Anvit Rai
    Psychology, Columbia University, New York, New York, United States
    Medical student, Albert Einstein College of Medicine, Bronx, New York, United States
  • Sol La Bruna
    Psychology, Columbia University, New York, New York, United States
  • Jennifer Kerr
    Psychology, Columbia University, New York, New York, United States
  • Grace Mao
    Psychology, Columbia University, New York, New York, United States
  • Emmanouil Tsamis
    Psychology, Columbia University, New York, New York, United States
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Ari Leshno
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Carlos G DeMoraes
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • George A Cioffi
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Jeffrey M Liebmann
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Donald C Hood
    Psychology, Columbia University, New York, New York, United States
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Footnotes
    Commercial Relationships   Anvit Rai None; Sol La Bruna None; Jennifer Kerr None; Grace Mao None; Emmanouil Tsamis None; Ari Leshno None; Carlos DeMoraes Galimedix, Perfuse Therapeutics, Carl Zeiss Meditec Inc, Novartis, Code C (Consultant/Contractor), Ora Clinical Inc., Code E (Employment), Topcon Inc, Code F (Financial Support), Heidelberg Engineering Inc, Code R (Recipient); George Cioffi None; Jeffrey Liebmann None; Donald Hood Topcon Inc, Heidelberg Engineering Inc, Novartis, Code C (Consultant/Contractor), Heidelberg Engineering Inc, Novartis, Code F (Financial Support), Topcon Inc, Heidelberg Engineering Inc, Novartis , Code R (Recipient)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 636 – A0376. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Anvit Rai, Sol La Bruna, Jennifer Kerr, Grace Mao, Emmanouil Tsamis, Ari Leshno, Carlos G DeMoraes, George A Cioffi, Jeffrey M Liebmann, Donald C Hood; Test of the Robustness of an OCT-based Method for Identifying Glaucomatous Damage Across Different Instruments. Invest. Ophthalmol. Vis. Sci. 2022;63(7):636 – A0376.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To test the Columbia University (CU) OCT-based method [1,2] for distinguishing glaucomatous damage from healthy controls by applying it to scans from different OCT instruments.

Methods : OCT glaucoma reports [3] were analyzed from 116 eyes from a prospective, observational, case-control study, included 54 healthy controls (HC), 32 early (EG, 24-2 mean deviation (MD) >-6dB), 12 moderate (MG, MD <-6dB and >-12dB), and 18 advanced glaucoma (AG, MD <-12dB). Eyes were scanned with two commercially available OCT instruments from different manufacturers, A and B. Each instrument uses different technology (swept-source vs. spectral-domain), segmentation algorithms, and normative data. A set of reports was generated for each device. These reports [3] included thickness and probability (p-) maps from both the retinal nerve fiber layer (RNFL) and ganglion cell layer (GCL), as well as a circumpapillary (cp) b-scan image and cpRNFL thickness plot. Four graders, experienced with the CU OCT-based method, categorized each eye as glaucoma (G), not glaucoma (NG), or uncertain (UNC) based upon clearly defined rules (Fig. 1).[1,2] Disagreements were adjudicated. Eyes with grades of UNC were treated as G in calculating specificity and sensitivity, as both grades require additional testing.

Results : For 113 (97%) of the 116 eyes, the grades were identical (Table 1). All 3 disagreements involved an UNC grade for either the A or B report. After combining eyes with UNC and G grades, the specificity for the 54 HC eyes was 98% (A) and 96% (B), while the sensitivity for the 62 G eyes was 100% for both A and B instruments.

Conclusions : The CU OCT-based method showed consistency across instruments from different manufacturers, with different normative groups and different algorithms. The sensitivity and specificity suggested that this method may help physicians distinguish glaucomatous eyes from healthy controls using OCT. 1. Liebmann et al; 2022; 2. Hood et al., PRER, 2022; 3. Hood PRER, 2017.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×